Search
for
Sort by
Research 91–120 of 235
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
- The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
- Testosterone: The Male Sex Hormone
- Cold Atmospheric Plasma for Breast Cancer
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Answers to CME examination
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Association of lichen planopilaris with seborrheic dermatitis: A retrospective case-control study
- Epidermal Stem Cells Cultured on Collagen-Modified Chitin Membrane Induce In Situ Tissue Regeneration of Full-Thickness Skin Defects in Mice
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Polarized microscopy in genetic hair disorders: case series
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Is dehydroepiandrosterone a hormone?
- INTERFERONS IN DERMATOLOGY
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Subject Index
- Issue Information
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Alopecia With Endocrine Therapies in Patients With Cancer